All articles tagged with #genetic testing
Parents of children with SMA advocate for universal newborn screening to enable early diagnosis and treatment, highlighting the stark difference in outcomes between their children who were tested early and those who were not, with the UK considering expanding screening programs amid promising new treatments.
Diane Davis's advanced ovarian cancer was initially thought incurable until molecular testing revealed she had Lynch syndrome, a genetic condition that made her cancer more responsive to immunotherapy, leading to a complete remission and highlighting the importance of genetic testing in cancer treatment.
A woman with advanced ovarian cancer was saved by identifying her rare genetic condition, Lynch syndrome, through molecular testing, which led to effective immunotherapy treatment and a significant remission, highlighting the importance of genetic diagnosis in cancer treatment.
The article discusses four key cancer screening tests for adults over 35—standard screenings like colonoscopy, mammograms, Pap smears, and PSA tests; advanced blood tests like Galleri; genetic testing for inherited risks; and full-body MRI scans—highlighting their importance for early detection and prevention, along with lifestyle factors influencing cancer risk.
A rare white Border Collie puppy with striking, otherworldly looks has gone viral, sparking curiosity about whether he is albino, double merle, or another genetic condition; genetic testing is planned to determine his exact genetics.
Liv Heeney from Birmingham, at risk of early onset dementia due to a faulty gene inherited from her mother Bernie, is using genetic testing and IVF to prevent passing the gene to her children, while raising awareness and funds for dementia research.
Jill Martin, a breast cancer survivor, shares her journey through diagnosis, treatment, and recovery, emphasizing the importance of genetic testing and research in saving lives. She is now raising awareness and funds through her brand, The Warrior Effect, to support breast cancer research and encourages women to learn about their genetic risk to prevent or better manage the disease.
A cluster of young adults in south Wales is affected by DRPLA, a rare inherited neurological disorder with no current cure, prompting efforts to raise awareness, improve diagnosis, and explore potential treatments through clinical trials.
A new polygenic score test developed by international researchers can predict a child's risk of developing high BMI and obesity in adulthood before age five, potentially allowing early intervention through healthier habits. The test, which is more accurate than previous versions, uses genetic data from over 5 million people and can explain a significant portion of BMI variation, especially in European populations. While genetics only partially determine BMI, early prediction offers a valuable window for preventive measures, although accuracy varies across different populations.
A large international study has developed a genetic test that predicts the risk of obesity, especially in children, with higher accuracy for individuals of European ancestry. The test uses a polygenic risk score that accounts for genetic variants linked to higher BMI, potentially enabling early interventions. However, its effectiveness varies across different populations, and lifestyle factors remain crucial in obesity risk management.
A large-scale study has developed a genetic test that can predict a child's risk of obesity in adulthood, potentially enabling early interventions. The test, based on a polygenic risk score, is more effective than previous methods, especially for individuals of European ancestry, and highlights the importance of combining genetic insights with lifestyle factors to address obesity. Further research is needed to improve accuracy across diverse populations.
A new investigation reveals that GLP-1 drugs like Ozempic may have more serious and potentially deadly side effects, including pancreatitis and fatalities, with genetic factors possibly influencing individual risk, prompting calls for genetic testing to prevent adverse effects.
The author’s sister Lindsey decides to get tested for Huntington’s disease during a visit, highlighting the complex emotional and ethical considerations involved in genetic testing for incurable diseases.
Anne Wojcicki's nonprofit TTAM Research Institute has received court approval to purchase 23andMe's assets for $305 million, ending a bidding war and marking the company's exit from bankruptcy. The deal includes the company's DNA testing services, research operations, and a telehealth subsidiary, with commitments to data privacy and customer protections. The acquisition's future leadership and regulatory challenges remain uncertain.
Anne Wojcicki's nonprofit TTAM Research Institute has been approved to buy back 23andMe for $305 million after the company's bankruptcy, marking a significant turnaround. The deal includes key assets like the DNA testing service and research operations, amid ongoing privacy concerns and legal challenges related to customer data. Wojcicki aims to continue the company's mission to democratize access to genetic information, with commitments to privacy and transparency.